01 September 2005
Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.
Shih-Jen TsaiMed Sci Monit 2005; 11(9): HY39-45 :: ID: 428439
Abstract
The "glutamate hypothesis" of schizophrenia has emerged from the findingthat phencyclidine (PCP) induces psychotic-like behaviors in rodents, possibly by blocking the N-methyl-D-aspartate(NMDA) subtype of glutamate receptor, thereby causing increased glutamate release. N-acetyl aspartylglutamate(NAAG), an endogenous peptide abundant in mammalian nervous systems, is localized in certain brain cells,including cortical and hippocampal pyramidal neurons. NAAG is synthesized from N-acetylaspartate (NAA)and glutamate, and NAA availability may limit the rate of NAAG synthesis. Although NAAG is known to havesome neurotransmitter-like functions, NAA does not. NAAG is a highly selective agonist of the type 3metabotropic glutamate receptor (mGluR3, a presynaptic autoreceptor) and can inhibit glutamate release.In addition, at low levels, NAAG is an NMDA receptor antagonist, and blocking of NMDA receptors may increaseglutamate release. Taken together, low central NAAG levels may antagonize the effect of glutamate atNMDA receptors and decrease its agonistic effect on presynaptic mGluR3; both activities could increaseglutamate release, similar to the increase demonstrated in the PCP model of schizophrenia. In this report,it is suggested that the central NAAG deficit, possibly through decreased synthesis or increased degradationof NAAG, may play a role in the pathogenesis of schizophrenia. Evidence is presented and discussed frommagnetic resonance, postmortem, animal model, schizophrenia treatment, and genetic studies. The centralNAAG deficit model of schizophrenia could explain the disease process, from the perspectives of bothneurodevelopment and neurodegeneration, and may point to potential treatments for schizophrenia.
Keywords: Dipeptides - metabolism, Brain - metabolism, Aspartic Acid - metabolism, Glutamic Acid - metabolism, Models, Neurological, Receptors, N-Methyl-D-Aspartate - metabolism, Schizophrenia - metabolism
775 10
Editorial
01 December 2023 : Editorial
Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory InfectionsDOI: 10.12659/MSM.943312
Med Sci Monit 2023; 29:e943312
In Press
08 Dec 2023 : Clinical Research
Association Between Influenza Vaccine Uptake and Health Awareness: A Cross-Sectional Questionnaire-Based St...Med Sci Monit In Press; DOI:
04 Dec 2023 : Animal Research
Effects of Intrathecal Ketamine on Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor and Mech...Med Sci Monit In Press; DOI:
01 Dec 2023 : Clinical Research
Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective St...Med Sci Monit In Press; DOI:
30 Nov 2023 : Review article
Decoding the Neurological Sequelae of General Anesthesia: A ReviewMed Sci Monit In Press; DOI:
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292